SLC6A1

Clinical trials for SLC6A1 explained in plain language.

Never miss a new study

Get alerted when new SLC6A1 trials appear

Sign up with your email to follow new studies for SLC6A1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First gene therapy injection targets rare brain disorder

Disease control ENROLLING_BY_INVITATION

This early-phase trial tests a one-time gene therapy injection into the spinal fluid for people with SLC6A1 neurodevelopmental disorder, a rare genetic condition. The study involves just 1 participant and will monitor safety and changes in behavior and development over 3 years. T…

Matched conditions: SLC6A1

Phase: PHASE1, PHASE2 • Sponsor: Emily de los Reyes • Aim: Disease control

Last updated Jun 26, 2026 17:08 UTC

SLC6A1

Get alerted when new SLC6A1 trials appear

First gene therapy injection targets rare brain disorder